Open AccessReal-world evidence of safety profile of intravitreal bevacizumab (Avastin) in an Indian scenario
Author(s) -
Priyanka Jain,
Jay Sheth,
Giridhar Anantharaman,
Mahesh Gopalakrishnan
Publication year - 2017
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_992_16
Subject(s) - medicine , bevacizumab , ophthalmology , endophthalmitis , macular degeneration , intraocular pressure , glaucoma , ranibizumab , adverse effect , branch retinal vein occlusion , central retinal vein occlusion , macular edema , visual acuity , surgery , chemotherapy
The purpose of this study was to evaluate the safety profile of intravitreal bevacizumab (Avastin) as an off-label pharmacotherapeutic agent for various ocular conditions.